MED1 and breast cancer: The pro-adipogenic transcriptional regulators, PPARγ binding protein (PBP) and RevERBα/NR1D1 cooperatively contribute to increased expression of pro-lipogenic enzymes and a unique, Warburg-like metabolism in HER2/neu-positive breast cancer cells [6].